JPH09500634A - ニチニチソウからの抗有糸分裂性の2成分アルカロイド誘導体 - Google Patents
ニチニチソウからの抗有糸分裂性の2成分アルカロイド誘導体Info
- Publication number
- JPH09500634A JPH09500634A JP7504973A JP50497395A JPH09500634A JP H09500634 A JPH09500634 A JP H09500634A JP 7504973 A JP7504973 A JP 7504973A JP 50497395 A JP50497395 A JP 50497395A JP H09500634 A JPH09500634 A JP H09500634A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- general formula
- deoxy
- compounds
- difluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 一般式1: (式中、 nは1または2であり、 R1はメチル基またはホルミル基を表し; R2はメトキシ基またはアミノ基を表し; R3は水素原子またはアセチル基を表す) に相当するニチニチソウ(Catharanthus roseus)からの2 成分アルカロイドの新規な抗有糸分裂性誘導体、並びにそれらの治療上許容され る無機または有機酸との塩、それらの化合物の炭素20′の2つの配置に対応す るジアステレオアイソマーの混合物およびあらゆる割合でのそれらの混合物。 2. 下記の化合物: − 19′,19′−ジフルオロ15′,20′−ジヒドロビノレルビン − 20′−デオキシ19′,19′−ジフルオロビンブラスチン − 20′−デオキシ19′,19′−ジフルオロビンデシン − Na−デメチルNa−ホルミル19′,19′−ジフルオロ15′, 20′−ジヒドロビノレルビン − 20′−デオキシ19′,19′−ジフルオロビンクリスチン − 17′−デアセチル19′,19′−ジフルオロ15′,20′−ジヒド ロビノレルビン − 17′−デアセチル20′−デオキシ19′,19′−ジフルオロビンブ ラスチン から選択されることを特徴とする、請求項1に記載の一般式1の化合物。 3. 一般式2の化合物を、ハロゲン化剤の存在下、弗化水素酸HFのような ブレーンステッド酸と五弗化アンチモンSbFSのようなルイス酸との組み合わ せから生ずる超強酸媒質中で、下記の反応図式: に従って反応させることを特徴とする、請求項1および2に記載の化合物の製造 方法。 4. 超強酸媒質中での一般式2の化合物の反応を−60℃および−15℃の 間の温度で行うことを特徴とする、請求項3に記載の化合物の製造方法。 5. ハロゲン化剤が: − 臭素 − 次亜塩素酸カルシウム − N−クロロスクシンイミド − N−ブロモスクシンイミド から選択されることを特徴とする、請求項3に記載の化合物の製造方法。 6. R3がアセチル基を表す一般式1の化合物を、下記の反応図式: (式中、3はR3=COCH3であるときの化合物1に相当し、4はR3=Hであ るときの化合物1に相当する) に従って加水分解することを特徴とする、請求項1および2に記載の、R3が水 素原子を表す一般式1の化合物の製造方法。 7. 加水分解がメタノール中ナトリウムメトキシドを用いて行われることを 特徴とする、請求項6に記載の化合物の製造方法。 8. 新規な医薬生成物としての、例えばヒトにおいて癌の治療に有用な、請 求項1および2のいずれかに記載の化合物。 9. 有効成分として請求項1および2のいずれかに記載の化合物の少なくと も一つを、薬学的に許容される賦形剤と組み合わせて含有することを特徴とする 、医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9308948A FR2707988B1 (fr) | 1993-07-21 | 1993-07-21 | Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant. |
FR93/08948 | 1993-07-21 | ||
PCT/FR1994/000898 WO1995003312A1 (fr) | 1993-07-21 | 1994-07-19 | Derives antimitotiques des alcaloides binaires du catharanthus roseus |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09500634A true JPH09500634A (ja) | 1997-01-21 |
JP3606872B2 JP3606872B2 (ja) | 2005-01-05 |
Family
ID=9449457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50497395A Expired - Lifetime JP3606872B2 (ja) | 1993-07-21 | 1994-07-19 | ニチニチソウからの抗有糸分裂性の2成分アルカロイド誘導体 |
Country Status (15)
Country | Link |
---|---|
US (1) | US5620985A (ja) |
EP (1) | EP0710240B1 (ja) |
JP (1) | JP3606872B2 (ja) |
AT (1) | ATE146477T1 (ja) |
AU (1) | AU693460B2 (ja) |
BR (1) | BR1100311A (ja) |
CA (1) | CA2167694C (ja) |
DE (2) | DE69401216T2 (ja) |
DK (1) | DK0710240T3 (ja) |
ES (1) | ES2097659T3 (ja) |
FR (2) | FR2707988B1 (ja) |
GR (1) | GR3022659T3 (ja) |
LU (1) | LU91660I2 (ja) |
NZ (2) | NZ269172A (ja) |
WO (1) | WO1995003312A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009167196A (ja) * | 1997-04-10 | 2009-07-30 | Pierre Fabre Medicament | ビンカアルカロイドの抗有糸分裂性ハロ誘導体 |
JP2009527480A (ja) * | 2006-02-17 | 2009-07-30 | ノバセア インコーポレイティッド | ビンカアルカロイドn酸化物および類似体による過剰増殖疾患の処置 |
JP2010504303A (ja) * | 2006-09-20 | 2010-02-12 | ピエール、ファーブル、メディカマン | フッ素化カタランチン誘導体、それらの製造、およびビンカ二量体アルカロイド前駆体としてそれらの利用 |
JP2010516790A (ja) * | 2007-01-29 | 2010-05-20 | 中国科学院上海薬物研究所 | 新規なビンブラスチン誘導体、その調製方法と用途、及び該誘導体を含む医薬組成物 |
JP2010518145A (ja) * | 2007-02-13 | 2010-05-27 | ピエール、ファーブル、メディカマン | 無水結晶ビンフルニン塩、その製造方法ならびに薬物およびビンフルニン精製手段としてのその使用 |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2737208A1 (fr) * | 1995-07-28 | 1997-01-31 | Pf Medicament | Nouvelles fluorovindolines, precurseurs d'analogues de la vinblastine et de la vinorelbine,leurs procedes de preparation et leur utilisation comme medicament |
FR2783522A1 (fr) * | 1998-09-21 | 2000-03-24 | Pf Medicament | Composes derives d'alcaloides de vinca, leur preparation et leur application en therapeutique |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
US6890558B2 (en) * | 2002-05-31 | 2005-05-10 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
AU2004296191B2 (en) | 2003-12-04 | 2010-10-28 | Albany Molecular Research, Inc. | Vinca derivatives |
WO2005055943A2 (en) | 2003-12-04 | 2005-06-23 | Amr Technology, Inc. | Vinorelbine derivatives |
FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
US20110015221A1 (en) * | 2003-12-23 | 2011-01-20 | Pierre Fabre Medicament | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
ATE507240T1 (de) * | 2004-03-05 | 2011-05-15 | Vegenics Pty Ltd | Materialien und verfahren für wachstumsfaktorbindende konstrukte |
FR2894966B1 (fr) * | 2005-12-20 | 2008-03-14 | Pierre Fabre Medicament Sa | Nouvelle forme cristalline de la vinflunine |
CN101108859A (zh) * | 2006-07-17 | 2008-01-23 | 上海恒瑞医药有限公司 | 长春碱类化合物、其制备方法及其在医药上的用途 |
WO2008033935A2 (en) * | 2006-09-12 | 2008-03-20 | Amr Technology, Inc. | Vinorelbine derivatives |
US8039453B2 (en) * | 2006-09-12 | 2011-10-18 | Albany Molecular Research, Inc. | Vinca derivatives |
EP1997534A1 (en) * | 2007-05-31 | 2008-12-03 | Pierre Fabre Medicament | Cancer treatment combination therapy comprising vinflunine and trastuzumab |
FR2918566B1 (fr) | 2007-07-11 | 2009-10-09 | Pierre Fabre Medicament Sa | Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine. |
FR2918567B1 (fr) * | 2007-07-11 | 2012-08-03 | Pf Medicament | Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine. |
US20090076055A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched vinflunine |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
PA8855601A1 (es) | 2008-12-23 | 2010-07-27 | Forformidatos de nucleósidos | |
CA2748034A1 (en) | 2008-12-23 | 2010-07-01 | Pharmasset, Inc. | Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections |
CN102325783A (zh) | 2008-12-23 | 2012-01-18 | 法莫赛特股份有限公司 | 嘌呤核苷的合成 |
DK2547359T3 (en) | 2010-03-15 | 2016-06-06 | The Board Of Trustees Of The Univ Of Illionis | Inhibitors of beta integrin G-protein alpha subunit-BINDING INTERACTIONS |
SG184323A1 (en) | 2010-03-31 | 2012-11-29 | Gilead Pharmasett Llc | Stereoselective synthesis of phosphorus containing actives |
EP2655401B1 (en) | 2010-12-20 | 2016-03-09 | The Regents of the University of Michigan | Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
CN103788117A (zh) * | 2012-10-30 | 2014-05-14 | 何小解 | 一种脱水长春碱、长春瑞滨及长春氟宁连续化合成工艺 |
HU230462B1 (hu) | 2013-05-30 | 2016-07-28 | Richter Gedeon Nyrt. | Új bisz-indol alkaloidok mint rákellenes gyógyszerek |
US9783547B2 (en) | 2014-01-15 | 2017-10-10 | Centre National De La Recherche Scientifique (Cnrs) | Water soluble 4-azapodophyllotoxin analogs |
US10308719B2 (en) | 2015-01-26 | 2019-06-04 | The University Of Chicago | IL13Rα2 binding agents and use thereof in cancer treatment |
CN107835820B (zh) | 2015-01-26 | 2021-10-15 | 芝加哥大学 | 识别癌症特异性IL13Rα2的CAR T细胞 |
RU2730521C2 (ru) * | 2016-03-09 | 2020-08-24 | Синбиас Фарма АГ | Винорелбина монотартрат и его фармацевтическое применение |
WO2018007554A1 (en) | 2016-07-06 | 2018-01-11 | Pierre Fabre Medicament | Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination |
AU2018314227A1 (en) | 2017-08-07 | 2020-02-06 | Amgen Inc. | Treatment of triple negative breast cancer or colorectal cancer with liver metastases with an anti PD-L1 antibody and an oncolytic virus |
CN114174340A (zh) | 2019-03-20 | 2022-03-11 | 加利福尼亚大学董事会 | 密封蛋白-6抗体和药物缀合物 |
BR112021021663A2 (pt) | 2019-04-30 | 2022-05-17 | Inst De Medicina Molecular Joao Lobo Antunes | Inibidores da via rank em combinação com inibidores de cdk |
CA3140904A1 (en) | 2019-06-24 | 2020-12-30 | Amgen Inc. | Inhibition of sirp-gamma for cancer treatment |
FR3140369A1 (fr) | 2022-10-04 | 2024-04-05 | Universite De Poitiers | Procédé de fluoration et/ou cyclisation d’un alcène ou alcyne aminé en flux continu et installation pour la mise en œuvre du procédé |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2296418B1 (ja) * | 1974-12-30 | 1978-07-21 | Anvar | |
US4110330A (en) * | 1977-05-27 | 1978-08-29 | Eli Lilly And Company | 5'-Acetonylvincristine and related compounds |
US4203898A (en) * | 1977-08-29 | 1980-05-20 | Eli Lilly And Company | Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids |
US4307100A (en) * | 1978-08-24 | 1981-12-22 | Agence Nationale De Valorisation De La Recherche (Anvar) | Nor bis-indole compounds usable as medicaments |
US4320058A (en) * | 1980-12-29 | 1982-03-16 | Eli Lilly And Company | 20'-Hydroxyvinblastine and related compounds |
HU193772B (en) * | 1985-06-12 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing new nitro-bis-indole derivatives |
-
1993
- 1993-07-21 FR FR9308948A patent/FR2707988B1/fr not_active Expired - Lifetime
-
1994
- 1994-07-19 ES ES94922935T patent/ES2097659T3/es not_active Expired - Lifetime
- 1994-07-19 JP JP50497395A patent/JP3606872B2/ja not_active Expired - Lifetime
- 1994-07-19 AT AT94922935T patent/ATE146477T1/de active
- 1994-07-19 US US08/578,669 patent/US5620985A/en not_active Expired - Lifetime
- 1994-07-19 AU AU72666/94A patent/AU693460B2/en not_active Expired
- 1994-07-19 NZ NZ269172A patent/NZ269172A/en not_active IP Right Cessation
- 1994-07-19 EP EP94922935A patent/EP0710240B1/fr not_active Expired - Lifetime
- 1994-07-19 DE DE69401216T patent/DE69401216T2/de not_active Expired - Lifetime
- 1994-07-19 WO PCT/FR1994/000898 patent/WO1995003312A1/fr active IP Right Grant
- 1994-07-19 DK DK94922935.5T patent/DK0710240T3/da active
- 1994-07-19 CA CA002167694A patent/CA2167694C/fr not_active Expired - Lifetime
- 1994-07-19 DE DE122010000012C patent/DE122010000012I1/de active Pending
-
1997
- 1997-02-26 GR GR970400346T patent/GR3022659T3/el unknown
- 1997-04-22 BR BR1100311-1A patent/BR1100311A/pt active IP Right Grant
- 1997-08-27 NZ NZ328612A patent/NZ328612A/xx not_active IP Right Cessation
-
2010
- 2010-03-04 FR FR10C0012C patent/FR10C0012I2/fr active Active
- 2010-03-10 LU LU91660C patent/LU91660I2/fr unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009167196A (ja) * | 1997-04-10 | 2009-07-30 | Pierre Fabre Medicament | ビンカアルカロイドの抗有糸分裂性ハロ誘導体 |
JP2009527480A (ja) * | 2006-02-17 | 2009-07-30 | ノバセア インコーポレイティッド | ビンカアルカロイドn酸化物および類似体による過剰増殖疾患の処置 |
JP2010504303A (ja) * | 2006-09-20 | 2010-02-12 | ピエール、ファーブル、メディカマン | フッ素化カタランチン誘導体、それらの製造、およびビンカ二量体アルカロイド前駆体としてそれらの利用 |
JP2010516790A (ja) * | 2007-01-29 | 2010-05-20 | 中国科学院上海薬物研究所 | 新規なビンブラスチン誘導体、その調製方法と用途、及び該誘導体を含む医薬組成物 |
JP2010518145A (ja) * | 2007-02-13 | 2010-05-27 | ピエール、ファーブル、メディカマン | 無水結晶ビンフルニン塩、その製造方法ならびに薬物およびビンフルニン精製手段としてのその使用 |
Also Published As
Publication number | Publication date |
---|---|
AU693460B2 (en) | 1998-07-02 |
NZ269172A (en) | 1997-10-24 |
ES2097659T3 (es) | 1997-04-01 |
DE122010000012I1 (de) | 2010-07-08 |
FR10C0012I2 (ja) | 2011-04-01 |
FR2707988A1 (fr) | 1995-01-27 |
DE69401216D1 (de) | 1997-01-30 |
BR1100311A (pt) | 1999-08-31 |
CA2167694A1 (fr) | 1995-02-02 |
ATE146477T1 (de) | 1997-01-15 |
EP0710240A1 (fr) | 1996-05-08 |
LU91660I2 (fr) | 2010-05-10 |
GR3022659T3 (en) | 1997-05-31 |
DE69401216T2 (de) | 1997-07-03 |
DK0710240T3 (da) | 1997-06-02 |
NZ328612A (en) | 2000-05-26 |
WO1995003312A1 (fr) | 1995-02-02 |
CA2167694C (fr) | 2007-03-06 |
FR10C0012I1 (ja) | 2010-04-16 |
US5620985A (en) | 1997-04-15 |
AU7266694A (en) | 1995-02-20 |
JP3606872B2 (ja) | 2005-01-05 |
FR2707988B1 (fr) | 1995-10-13 |
EP0710240B1 (fr) | 1996-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3606872B2 (ja) | ニチニチソウからの抗有糸分裂性の2成分アルカロイド誘導体 | |
EP0436653A1 (en) | Synthesis of camptothecin and analogs thereof | |
PT95662A (pt) | Processo de inibicao da enzima topoisomerase i com camptotecina e de preparacao de composicoes farmaceuticas | |
JPH08506333A (ja) | イミダゾピリジン及び胃腸の疾病の治療のためのその使用 | |
US5364858A (en) | Camptothecin analogs as potent inhibitors of topoisomerase I | |
IE921148A1 (en) | Anti-tumor and anti-psoriatic agents | |
JPS6150985A (ja) | 新規なカンプトテシン誘導体 | |
Kam et al. | Structure and biomimetic, electrochemically-mediated semisynthesis of the novel pentacyclic indole danuphylline | |
JPS634835B2 (ja) | ||
Bosch et al. | Studies on the synthesis of pentacyclic strychnos indole alkaloids. Photocyclization of n-chloroacetyl-1, 2, 3, 4, 5, 6-hexahydro-1, 5-methanoazocino [4, 3-b] indole derivatives | |
HU176226B (en) | Process for producing 4-deacetyl- or 4-deacetoxy-vinblastin-3-carboxamide derivatives | |
WO2001002408A1 (en) | Novel xanthone compounds, their preparation and use as medicament | |
IL28388A (en) | History 1, 6 - Dimethyl - A 01 - Argolin | |
US4279916A (en) | Method of treatment using new leurosine derivatives | |
EP0207336B1 (en) | Nitro derivatives of vinblastine-type bis-indoles, a process for preparing same and pharmaceutical compositions containing them | |
Manna et al. | Synthesis of the alkaloid nauclefidin | |
US4895852A (en) | Antitumor alkaloids | |
KR850001919B1 (ko) | 20'-하이드록시 빈블라스틴 및 유사화합물의 제조방법 | |
US5043336A (en) | Cyclic imide derivatives of 4-desacetyl VLB c-3 carboxhydrazide | |
CA1088526A (en) | 4'-deoxyvincristine and related compounds | |
KR810001983B1 (ko) | 1-포르밀 인돌-디하이드로인돌 이량체의 제조방법 | |
KR830002079B1 (ko) | 4'-데옥시 vlb "a"와 "b" 및 관련 1-포르밀 화합물의 3'-산화된 유도체의 제조방법 | |
JPS5910358B2 (ja) | 新規エルゴリン誘導体 | |
WO1988000198A1 (en) | Antitumor alkaloids | |
KR880001573B1 (ko) | 안트라사이클린 글리코사이드의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040419 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040607 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040720 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040907 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20041006 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081015 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091015 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091015 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101015 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111015 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121015 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131015 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term |